Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin Promotes John Springate to President of Kemin Agrifoods - Kemin Industries announces the appointment of John Springate to president of Kemin Agrifoods world wide.  In this role, Springate is responsible for overseeing the global agrifoods business of Kemin
Kemin Promotes John Springate to President of Kemin Agrifoods

 

PRZOOM - /newswire/ - Herentals, Belgium, 2009/12/21 - Kemin Industries announces the appointment of John Springate to president of Kemin Agrifoods world wide. In this role, Springate is responsible for overseeing the global agrifoods business of Kemin.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Having served as president of Kemin Europe and Kemin Asia, Springate has significantly contributed to the global growth and overall success of Kemin Industries’ agrifoods business.

“John has been instrumental in achieving exponential growth of Kemin’s agrifoods business in both Europe and Asia,” says Chris Nelson, president and CEO of Kemin Industries. “Through his strategic leadership in this new role, John will continue to grow the Kemin agrifoods business world wide.”

“I look forward to leading Kemin Agrifoods as we evaluate and implement strategies for global animal production,” says Springate. “Through our regional operations we will continue to meet the unique needs of each market and to serve our customers. Our global unit will ensure that regional strategies align with the overall vision of Kemin Agrifoods.”

Having served as business manager, global product manager, commercial manager and senior vice president for companies including Unilever, Biomar and Roche, Springate has many years of experience of management in the global agricultural business.

Springate received his undergraduate degree in applied biology in London and Ph.D in aquaculture from the University of Aston in Birmingham.

Kemin® – Inspired Molecular Solutions™
Founded in 1961, the Kemin group of companies (kemin.com) provide health and nutritional solutions to the agrifoods, food ingredients, pet food, human health and pharmaceutical industries. Kemin operates in more than 60 countries with manufacturing facilities in Belgium, Brazil, China, India, Singapore, South Africa, Thailand and the United States.

The AgriFoods businesses of Kemin focus on Total Nutrition™ to help customers achieve a highly effective, consistent system of profitable animal production. The essential combination of Kemin products with good nutrition and solid animal husbandry ensures that customers around the globe maintain profitability while enhancing the health and well being of animals.

For media inquiries, please contact:
Stephanie Wilson, 515-559-5482, stephanie.wilson[.]kemin.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin Promotes John Springate to President of Kemin Agrifoods

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Erin Hockman - Kemin.com 
515-559-5349 n[.]kemin.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Kemin Industries, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment
Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory
SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs
Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma
New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS
Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients
U.S. FDA Grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in First Line Unfit Acute Myeloid Leukemia
Additional Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer in South Korea
BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow, Inc.

Visit  BizJobs.com







 
  ©2005-2026 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today